ADO 4.55% 2.3¢ anteotech ltd

The big inroad to most markets will be the SARS-COV-2/ influenza...

  1. 8,925 Posts.
    lightbulb Created with Sketch. 1933
    The big inroad to most markets will be the SARS-COV-2/ influenza A+B multiplex test. The next best test to including a test for RSV as well.

    Interestingly another group is working on a drug to control the body's Compliment System (suppress up to 85 days - in Clinical Trials now). So what's that to AnteoTech? Well that drug could prove a great benefit to some Sepsis patients with runaway C5a protein - they'll need a bloody good test for Sepsis though, as its not a thing to turn off particular with meningococcal.
    Last edited by Brickwalls: 05/04/21
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.3¢
Change
0.001(4.55%)
Mkt cap ! $54.31M
Open High Low Value Volume
2.2¢ 2.3¢ 2.2¢ $40.87K 1.804M

Buyers (Bids)

No. Vol. Price($)
1 50000 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 632081 4
View Market Depth
Last trade - 12.37pm 02/09/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.